The following organisations are receiving the list:
The Cabinet Office
The Cabinet Office received the list for the purpose of delivering the government's extremely vulnerable persons service which will provide additional support to clinically extremely vulnerable people and the local authorities affected by future lockdowns. This sharing ceased on 17 September 2021 based upon the government’s announcement of the end of Shielding in England.
Local authorities receive the list for the purpose of understanding and identifying clinically extremely vulnerable people to provide targeted support before, during, and following local outbreaks, offering help, social care and support in coordination with other relevant organisations as part of the local COVID-19 response.
Local Authorities are permitted to link SPL data with the Local Authority’s NHS Test and Trace data to identify people who are clinically extremely vulnerable that have come into contact with people recorded by NHS Test & Trace, and/or identify people who are clinically extremely vulnerable that have been directed to isolate by the NHS Test and Trace Service, in both cases to offer them appropriate advice and direct care.
NHS clinical commissioning groups
Clinical commissioning groups (CCGs) receive the list for the purpose of providing GP practices with support, and patients in their CCG area with support and care.
Capita receive the list for the purpose of distributing letters to shielded patients, on behalf of NHS England as their data processor.
APS Group Limited
APS Group receive the list for the purpose of distributing letters to shielded patients, on behalf of the Department of Health and Social Care as their data processor.
NHS Business Services Authority
The NHS Business Services Authority receive the list for the purpose of sending text messages to shielded patients, on behalf of DHSC as their data processor.
NHS Business Service Authority also operate the Prescription Payment Verification assurance function and following direction by NHS England, includes those functions for shielded patient pharmacy post payment verification. This is to ensure that the prescription delivery services provided to clinically extremely vulnerable patients who have been shielding and require prescription delivery support are operating effectively, and to ensure that public funds assigned for COVID-19 services to patients are being managed appropriately.
On behalf of DHSC and NHS England, NHS Digital’s data processor Gov.Notify, receive the list for the purpose of sending letters, emails and text messages to shielded patients.
Emails are being used in addition to letters to ensure where patients have an email address registered with the NHS, they receive timely information on their risk status, shielding policy, advice and guidance.
NHS England/NHS Improvement and TPP
NHS England/NHS Improvement and TPP receive the list for the purpose of identifying patients on the shielded patients list who are currently in prison and who need advice, support, and care.
Hospitals and GP practices
For the purpose of protecting patients in their care.
Data is disseminated to NHS England and NHS Improvement for the purposes of strategic commissioning. Data is pseudonymised and held on the NHS England data warehouse (NCDR). The NHS COVID‑19 Reference Library describes the datasets being used in the NHS COVID‑19 Data Store, and the sources of those datasets.
Data is also disseminated to NHS England and Improvement for the purposes of providing an SPL feed into the COVID-19 vaccination programme (using National Immunisation Management System (NIMS)). This supports the Joint Commission for Vaccinations and Immunisations (JCVI) who identified that patients who are Clinically Extremely Vulnerable should be offered a priority vaccination.
National Services Scotland
National Services Scotland are responsible for the Scottish Shielded Patient List. The purpose of sharing this information is so that NSS can contact the English patients to provide them with details of support they can obtain locally from Scottish local authorities where they are resident, including food parcels.
NHS Wales Informatics Service
NHS Wales Informatics Service (NWIS) are responsible for the Welsh Shielded Patient List. The purpose of sharing this information is so that NWIS can contact the English patients to provide them with details of support they can obtain locally from Welsh Local Authorities where they are resident, including food parcels.
Redbridge CCG are responsible for the 111 call handling systems for London. The purpose of sharing this information is to support an NHS England pilot programme, so that patients on the Shielded Patient List who call 111 and require referral to an emergency department will now be flagged as being on the Shielded Patient List - enabling clinicians to make appropriate care arrangements.
Mental health providers
Mental health providers are responsible for mental health services commissioned by CCG’s. The purpose of sharing this information is to support an NHS England policy, so that patients on the Shielded Patients List who are in receipt of mental health services from the provider can be proactively contacted and have their care plans reviewed. This is because shielding is an extreme course of action likely to have had significant impact on the shielding individual’s mental health.
Public Health England
Data has also been disseminated to Public Health England (PHE) for the purposes of COVID-19 vaccination programme surveillance. PHE has a role to monitor the delivery, safety and effectiveness of immunisation programmes in England and requires the SPL Data to improve the data set in order analyse the impact of COVID-19 vaccines for clinically extremely vulnerable people.
Department of Health and Social Care (DHSC)
Data is disseminated to the DHSC’s service provider, Paragon, for the purposes of supplying those clinically extremely vulnerable people who have registered for a free Vitamin D supplement via the Get Vitamin D Supplements service.
University of Oxford
SPL data was shared with the University of Oxford, for the development and validation of a risk prediction QCovid® risk calculator to estimate short term adverse outcomes from COVID-19 disease which can be used as a risk stratification tool and to inform national shielding policy.